Conference Coverage
Conference Coverage
Dasatinib gives letrozole a boost in HR-positive advanced breast cancer
Major finding: Adding dasatinib to letrozole did not improve the clinical benefit rate, but it more than doubled median progression-free survival...
Conference Coverage
Radiotherapy can be omitted for many older breast cancer patients
Major finding: The 5-year ipsilateral breast cancer recurrence rate in a selected population of older women undergoing breast-conserving surgery...
Conference Coverage
Sickle cell crises curtailed with experimental cellular adhesion inhibitor
Major finding: The mean time to resolution of vaso-occlusive crisis in patients with sickle cell disease was 103 hours for patients treated with...
Conference Coverage
VIDEO: Idelalisib shows promise in refractory non-Hodgkin lymphoma
Conference Coverage
Gene therapy for SCID-X1 may successfully reset immune system
Major finding: Of nine boys with X-linked severe combined immunodeficiency who were treated with gene therapy, seven patients have evidence of T-...
Conference Coverage
Obinutuzumab routs rituximab in older chronic lymphocytic leukemia patients
Major finding: Progression-free survival was 15.2 months with combination rituximab vs. 26.7 months with combination obinutuzumab (HR, 0.39; P...
Conference Coverage
Resurrected gemtuzumab shows benefit against pediatric AML
Major finding: Three-year event-free survival rates were 53% for children and young adults treated with gemtuzumab ozogamicin added to a standard...
Conference Coverage
Age barrier falls for half-matched bone marrow transplants
Major finding: Patients in their 50s, 60s, and 70s had similar estimated 2-year progression-free survival (39%, 36%, 39%) and overall survival (51...
Conference Coverage
Younger adults with brain metastases survive longer with radiosurgery alone
Major finding: Stereotactic radiosurgery was associated with significantly longer overall survival among patients age 50 years and younger (hazard...
Conference Coverage
Breast cancer hormone therapy may affect cognitive function
Major finding: The odds of any decline in cognitive function were significantly higher in patients on hormone therapy (OR, 7.7), compared with...
Conference Coverage
IMRT bests conventional radiation for soft-tissue sarcomas of the extremities
Major finding: The 5-year local control rate with intensity-modulated radiation therapy was 92.4%, compared with 85% for conventional external-...